On May 22-23, 2017, the NADFC conducted the Supervision on the Application of Pharmacovigilance for Drugs of AIDS and Malaria Program Drugs in Health Service Facilities in Jayapura City. This is the first activity done to implement the Ministerial Decree of the Ministry of Health No. HK.02.02/Menkes/164/2015 on the Trial the Pharmacovigilance Implementation for Drugs of AIDS, Tuberculosis and Malaria Program in Health Service Facilities.
The activity aimed at evaluating and supervising the implementation of the pharmacovigilance for drug of AIDS and Malaria program in health service facilities which are the try-out place according to the above-mentioned Ministerial Decree. A dissemination program on Guidance on Implementing Pharmacovigilance for AIDS, Tuberculosis and Malaria Program Drugs was given to the facilities in 2014. Furthermore, the activity was done to synchronize the perception and clarity of roles of each stakeholder in the national and regional levels so that a more structured coordination of pharmacovigilance implementation can be achieved.
The supervision activity was done by the Directorate of Distribution Control of Therapeutic Product and Household Medical Supplies of the Indonesian NADFC, together with the Sub-Directorate of Malaria Control and the Sub-Directorate of AIDS and Infectious Diseases Control of the Indonesian Ministry of Health, the Provincial Office of NADFC in Jayapura, the Provincial Public Health Office of Papua, and the Public Health Office of Jayapura.
The facilities to carry out the supervision program on the implementation of pharmacovigilance for AIDS and Malaria program drugs, as mentioned in the Ministerial Decree, are the Regional General Hospital of Jayapura and Hamadi Community Health Clinic (Puskesmas). Other than those health service facilities, Koya Barat Community Health Clinic also received the supervision program because based on the malaria report in Jayapura City in 2014 and 2015, all community health clinics in Jayapura became the areas for high-rate malaria endemic. Koya Barat Community Health Clinic was one of those which has the highest Annual Parasite Incidence (API).
It was expected that the supervision program on the implementation of pharmacovigilance can improve the safety of drug use, especially for program drugs for AIDS, Tuberculosis and Malaria. (as)